Compare CDNA & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | FOR |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2007 | 2007 |
| Metric | CDNA | FOR |
|---|---|---|
| Price | $28.90 | $30.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $28.00 | ★ $32.67 |
| AVG Volume (30 Days) | ★ 932.9K | 139.0K |
| Earning Date | 04-28-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.05 | ★ 0.93 |
| Revenue | $48,324,000.00 | ★ $1,662,400,000.00 |
| Revenue This Year | $16.01 | $0.34 |
| Revenue Next Year | $11.31 | $7.73 |
| P/E Ratio | $582.20 | ★ $32.54 |
| Revenue Growth | ★ 18.93 | 10.14 |
| 52 Week Low | $10.96 | $21.54 |
| 52 Week High | $30.00 | $32.06 |
| Indicator | CDNA | FOR |
|---|---|---|
| Relative Strength Index (RSI) | 65.45 | 55.78 |
| Support Level | $14.59 | $23.88 |
| Resistance Level | N/A | $30.74 |
| Average True Range (ATR) | 1.40 | 0.93 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 85.34 | 45.12 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.